Notes / Company

Orchid Pharma Ltd.

ORCHPHARMA BSE 524372 ISIN INE191A01027 Pharmaceuticals

Fundamentals

Market cap: ₹3,628 cr
P/E: 192.30×
ROE: 7.86%
Debt / equity: 0.14
52-week range: 480.00 — 899.00

The timeline — 1 note on Orchid Pharma Ltd.

May 2026

25 May 26 · 8:00 PM IST Brief

Brief · Earnings · Small cap

Orchid Pharma profit drops 79% as auditors flag US subsidiaries

Consolidated net profit fell to ₹20.5 crore for FY26, while auditors issued a qualified opinion on the company's accounts.

Verify on exchange BSE filings for ORCHPHARMA NSE filings for ORCHPHARMA